According to GlobalData’s medical device pipeline database, 104 Hematology devices are in various stages of development globally. GlobalData’s report Hematology provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 31 are in active development, while the remaining 74 are in an inactive stage of development. There are 15 products in the early stages of development, and the remaining 16 are in the late stages of development.
Hematology is the study of blood in healthy and diseased conditions. This category consists of Hematology reagents and rapid tests used for determination and diagnosis of both physiological and pathological aspects of blood and its components. The category includes “hemostasis” which has reagents & test kits used for determination and diagnosis of various clotting factors. Also, it comprises of immune related reagents used for analysis of blood and its components. Hematology comprises of following sub-segments – Hematology Reagents, Hematology Rapid Tests & POC, Hemostasis and Hematology analyzers.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Hematology pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Hematology devices. Overall, most of these Hematology pipeline devices are being developed by private entities.
Key players involved in the active development of Hematology include AliveDx Suisse, Transfusion & Transplantation Technologies, Biofortuna, Diagnostica Stago, Alba Bioscience, Sebia, Streck, Analyticon Biotechnologies, Ortho Clinical Diagnostics and PixCell Medical Technologies.
For a complete picture of the developmental pipeline for Hematology devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.